Skip to content

Drug interactions

Indacaterol + Panobinostat

Severity: Major

Indacaterol and Panobinostat: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Panobinostat significantly prolongs the QT interval and labeling advises against use with other QT-prolonging drugs. Indacaterol can add to QT and heart-rate effects, increasing arrhythmia risk.

What this interaction means in plain words

Indacaterol and Panobinostat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Indacaterol belongs to Respiratory; Panobinostat belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive QT prolongation and beta-adrenergic cardiac stimulation.

What to do

Avoid the combination and use an alternative if possible. If unavoidable, monitor ECG and keep potassium and magnesium in range.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol and Panobinostat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Indacaterol with Panobinostat?

MediHelp rates the interaction as major. Indacaterol and Panobinostat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Panobinostat significantly prolongs the QT interval and labeling advises against use with other QT-prolonging drugs. Indacaterol can add to QT and heart-rate effects, increasing arrhythmia risk.

How serious is the interaction between Indacaterol and Panobinostat?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and use an alternative if possible. If unavoidable, monitor ECG and keep potassium and magnesium in range.

What other medicines interact with Indacaterol?

MediHelp also lists interactions of Indacaterol with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Indacaterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in